While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...

Invasive lobular carcinoma (ILC) accounts for up to 15% of all invasive breast cancers and has long been recognized as being different from infiltrating ductal carcinoma (IDC). Now, a genomic ...

A multi-center analysis of patients with invasive lobular carcinoma, or ILC - the second most common histological subtype of invasive breast cancer in the U.S. - showed that, despite its prevalence, ...

The leaders of the MSK Lobular Breast Cancer program (from left), breast pathologist Fresia Pareja, MD, PhD; breast surgeon Anita Mamtani, MD; breast medical oncologist Sherry Shen, MD. The program is ...

The type of breast cancer that is diagnosed is determined by specific cells. Ductal carcinoma in situ, or DCIS, also known as intraductal carcinoma, is when the abnormal cells have not spread through ...

Lobular breast cancer patients gathered at Fred Hutch Cancer Center last week for a two-hour program featuring patient stories, epidemiological findings and new developments in screening and clinical ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window During a year-in ...

We report a patient in whom synchronous breast and gastric primaries were suspected to result from a germline CDH1 mutation, but which were ultimately explained by metastatic lobular breast carcinoma.

The SNMMI Mars Shot Research Fund is pleased to announce that Randy Yeh, MD, a radiologist and nuclear medicine physician at Mount Sinai Health System, associate professor of radiology, and chief of ...